| Mycobacterium tuberculosis‐specific CD8+ T cells are functionally and phenotypically different between latent infection and active disease V Rozot, S Vigano, J Mazza‐Stalder, E Idrizi, CL Day, M Perreau, ... European journal of immunology 43 (6), 1568-1577, 2013 | 221 | 2013 |
| Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis E Petruccioli, TJ Scriba, L Petrone, M Hatherill, DM Cirillo, SA Joosten, ... European Respiratory Journal 48 (6), 1751-1763, 2016 | 220 | 2016 |
| Tuberculosis biomarkers: from diagnosis to protection D Goletti, E Petruccioli, SA Joosten, THM Ottenhoff Infectious disease reports 8 (2), 6568, 2016 | 188 | 2016 |
| Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid … CWM Ong, GB Migliori, M Raviglione, G MacGregor-Skinner, G Sotgiu, ... European Respiratory Journal 56 (4), 2020 | 145 | 2020 |
| IFNγ/TNFα specific-cells and effector memory phenotype associate with active tuberculosis E Petruccioli, L Petrone, V Vanini, A Sampaolesi, G Gualano, E Girardi, ... Journal of Infection 66 (6), 475-486, 2013 | 133 | 2013 |
| A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients L Petrone, E Petruccioli, V Vanini, G Cuzzi, SN Fard, T Alonzi, C Castilletti, ... Clinical microbiology and infection 27 (2), 286. e7-286. e13, 2021 | 131 | 2021 |
| First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB Plus E Petruccioli, T Chiacchio, I Pepponi, V Vanini, R Urso, G Cuzzi, ... Journal of Infection 73 (6), 588-597, 2016 | 123 | 2016 |
| Polyfunctional T-cells and effector memory phenotype are associated with active TB in HIV-infected patients T Chiacchio, E Petruccioli, V Vanini, G Cuzzi, C Pinnetti, A Sampaolesi, ... Journal of Infection 69 (6), 533-545, 2014 | 118 | 2014 |
| Analytical evaluation of QuantiFERON-Plus and QuantiFERON-Gold In-tube assays in subjects with or without tuberculosis E Petruccioli, V Vanini, T Chiacchio, G Cuzzi, DM Cirillo, F Palmieri, ... Tuberculosis 106, 38-43, 2017 | 114 | 2017 |
| Coinfection of tuberculosis and COVID-19 limits the ability to in vitro respond to SARS-CoV-2 L Petrone, E Petruccioli, V Vanini, G Cuzzi, G Gualano, P Vittozzi, ... International journal of infectious diseases 113, S82-S87, 2021 | 85 | 2021 |
| QuantiFERON TB Gold Plus for the diagnosis of tuberculosis: a systematic review and meta-analysis G Sotgiu, L Saderi, E Petruccioli, S Aliberti, A Piana, L Petrone, D Goletti Journal of Infection 79 (5), 444-453, 2019 | 83 | 2019 |
| IP-10 is an additional marker for tuberculosis (TB) detection in HIV-infected persons in a low-TB endemic country V Vanini, E Petruccioli, C Gioia, G Cuzzi, N Orchi, A Rianda, L Alba, ... Journal of infection 65 (1), 49-59, 2012 | 83 | 2012 |
| Higher frequency of T-cell response to M. tuberculosis latency antigen Rv2628 at the site of active tuberculosis disease than in peripheral blood T Chiacchio, E Petruccioli, V Vanini, O Butera, G Cuzzi, L Petrone, ... PLoS One 6 (11), e27539, 2011 | 71 | 2011 |
| Assessment of CD27 expression as a tool for active and latent tuberculosis diagnosis E Petruccioli, L Petrone, V Vanini, G Cuzzi, A Navarra, G Gualano, ... Journal of Infection 71 (5), 526-533, 2015 | 63 | 2015 |
| Specific T Cells Restore the Autophagic Flux Inhibited by Mycobacterium tuberculosis in Human Primary Macrophages E Petruccioli, A Romagnoli, M Corazzari, EM Coccia, O Butera, G Delogu, ... Journal of Infectious Diseases 205 (9), 1425-1435, 2012 | 55 | 2012 |
| Evaluation of IP-10 in Quantiferon-Plus as biomarker for the diagnosis of latent tuberculosis infection L Petrone, V Vanini, T Chiacchio, E Petruccioli, G Cuzzi, V Schinina, ... Tuberculosis 111, 147-153, 2018 | 51 | 2018 |
| Clinical isolates of the modern Mycobacterium tuberculosis lineage 4 evade host defense in human macrophages through eluding IL-1β-induced autophagy A Romagnoli, E Petruccioli, I Palucci, S Camassa, E Carata, L Petrone, ... Cell death & disease 9 (6), 624, 2018 | 50 | 2018 |
| In-vitro evaluation of the immunomodulatory effects of Baricitinib: Implication for COVID-19 therapy L Petrone, E Petruccioli, T Alonzi, V Vanini, G Cuzzi, SN Fard, C Castilletti, ... Journal of Infection 82 (4), 58-66, 2021 | 47 | 2021 |
| Spike is the most recognized antigen in the whole-blood platform in both acute and convalescent COVID-19 patients A Aiello, SN Fard, E Petruccioli, L Petrone, V Vanini, C Farroni, G Cuzzi, ... International Journal of Infectious Diseases 106, 338-347, 2021 | 45 | 2021 |
| IL-4 specific-response in whole blood associates with human Cystic Echinococcosis and cyst activity L Petrone, V Vanini, E Petruccioli, GM Ettorre, EB Rizzi, V Schininà, ... Journal of Infection 70 (3), 299-306, 2015 | 44 | 2015 |
